IP Checkups custom patent monitoring and curation service supports Big Pharma Co’s successful launch of multi-billion dollar drug.
In an effort to develop best-in-class new chemical entities, in 2007, one of the world’s largest biopharma companies (~ $20 Billion market cap) turned to IP Checkups (IPC), a pioneer in patent research and analytics, to develop a system for the R&D team to track and monitor competitive patent information in real time.